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ABSTRACT
Background: Bothropic envenomation represents the most common ophidic accident worldwide, compared to other snake-
bites of medical interest. Bothropic venom has proteolytic, vasculotoxic, clotting and/or hemorrhagic actions in animals 
and humans. Mikania glomerata is a plant found in the Brazilian Atlantic Forest with interesting medical properties that 
may be useful in ameliorating the effects of ophidic venom, and thus, improving response and outcome. Although Mikania 
is known to act through inhibition of cytolysins in the venom, there is a lack of consistent research data. The aim of this 
study was to evaluate the effect of M. glomerata in bothropic envenomation treatment.
Materials, Methods & Results: Clinical, hematological, biochemical, and histopathological evaluations were performed 
following Bothropoides jararaca experimental envenomation in three groups of 18 Wistar rats each. Group VS was in-
oculated in the pelvic limb via intramuscular injection of bothropic venom and received specific anti-venom serum via 
intraperitoneal injection. Group VSM was similarly inoculated; it received anti-venom serum and a 10% aqueous extract 
of the Mikania glomerata plant orally. Group C was the control group and received saline solution alone. Evaluations 
were performed at 0.5 h (M1), 6 h (M2), and 24 h (M3) after venom inoculation. Animals from both inoculated groups 
(VS and VSM) showed significant clinical alterations (P < 0.05) manifested as discomfort, uneasiness, pain, and severe 
edema compared to control animals. Animals from inoculated groups also exhibited statistically significant leukocytosis 
with neutrophilia, and elevation of blood urea nitrogen and creatine kinase until 6 h after inoculation (P < 0.05 compared 
to control animals). An acute drop in body temperature was observed 6 h after inoculation (P < 0.05). High levels of cre-
atinine were observed at 6 and 24 h, and plasma protein reduction at almost all evaluation time points (P < 0.05) in both 
groups compared to that in control. Histopathological evaluation of venom-inoculated animals (groups VS and VSM) 
showed significant renal hydropic degeneration, acute tubular necrosis, congestion, and hemorrhage (P < 0.05 compared 
to control). In contrast, animals administered plant extract in addition to anti-venom (group VSM) showed milder muscular 
fiber regeneration and absence of hemorrhage in the inoculated limb, compared to those that received anti-venom alone 
(group VS). Overall, there were no statistically significant differences between the inoculated groups (P > 0.05) in terms 
of edema reduction, pain relief, hematological, biochemical, or histopathological alterations. 
Discussion: Clinical envenomation symptoms can be explained based on previous reports of bothropic events, where 
cytolysins such as hyaluronidase, phospholipase A2, and esterases are associated with alterations in cell membrane per-
meability and release of vasoactive agents. Rhabdomyolysis and muscular necrosis are the main causes of muscular and 
renal alterations in inoculated groups. M. glomerata extract is known to exert its inhibitory effects on vasoactive and lytic 
compounds responsible for muscular necrosis. However, some authors have reported only partial effectiveness of Mikania 
in inactivating bothropic toxins, in contrast with its greater inhibitory action on crotalic venoms. Further studies are neces-
sary for detailed exploration of the properties of Mikania glomerata extract in order to integrate it into supportive measures 
for snakebite treatments in tropical and subtropical countries.
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INTRODUCTION
Ophidic accidents are a problem in many parts 
of the world, especially in tropical and subtropical 
areas, with most cases caused by the Bothrops genus 
[1,15-17].
Bothropic venom, as a mixture of compounds, 
causes severe local and systemic reactions related to 
proteolytic, vasculotoxic, coagulant and/or hemor-
rhagic effects [1,13,15]. The above reactions are 
responsible for swelling, edema, necrosis, respiratory 
distress, disseminated intravascular coagulation, acute 
renal failure, and death [4,8,12,19].
Anti-ophidic serum is the only validated treat-
ment [4] for bothropic envenomation, but it needs to be 
accompanied by essential supportive measures such as 
hypovolemia correction, broad-spectrum antibiotics, 
tetanus prophylaxis, analgesia, and local management [1]. 
Serum therapy is not always accessible and its 
effectiveness is controversial, justifying the importance 
of new therapeutic strategies to reduce intensity and 
impact of envenomation effects [4,9]. Many plants have 
been used to ameliorate the effects of snakebite [1]. 
Among them, Mikania glomerata commonly known 
as “guaco,” a plant found in the Brazilian Atlantic For-
est, possesses multiple medical properties associated 
with its constituent coumarins and their derivatives–
terpenes, phytosterols, and flavonoids [14]. It may 
ameliorate the consequences of ophidic envenomation, 
probably through inhibition of phospholipase A2, me-
talloproteases, and serine proteases, which are enzymes 
associated with envenomation symptoms [2,9].
In this study, we aimed to evaluate effects of 
treatment with anti-venom or both anti-venom and 
aqueous extract of Mikania glomerata on experimental 
Bothropoides jararaca envenomation in Wistar rats.
MATERIALS AND METHODS
The experimental procedures used throughout 
this study were approved by the Local Ethics Commit-
tee on Animal Research. 
Animals and experimental groups
Fifty-four healthy female Wistar rats (Rattus 
norvegicus), weighing 250 ± 50 g, were housed in indi-
vidual stainless-steel cages and maintained under con-
trolled conditions (12 h light/dark cycle, 24 ± 1.0°C, 
60 ± 5.0 % humidity, and 10 cycles of air exchange, ad 
libitum filtered water and commercial food).
Animals were divided into three experimen-
tal groups of 18 animals each. Group Venom-Serum 
(Group VS) received 10 mg/kg of bothropic lyophilized 
venom1 via intramuscular injection in the rear left limb, 
and polyvalent anti-ophidic serum (Reg. No. 2817)2, 
as anti-venom, via intraperitoneal injection at 5 mL/
kg, 6 h after venom inoculation. Group Venom-Serum 
and Mikania (Group VSM) received the same dose of 
bothropic venom and anti-venom serum, and three 
doses of 10 mg/kg of M. glomerata aqueous leaf extract 
(10%, voucher specimem 16838, Botany Department 
IBB – UNESP, Botucatu, SP, Brazil)3 [5,9] via gavage, 
every 2 h after venom inoculation. The control group 
(Group C) received saline solution in place of the 
above treatments. 
Procedures
At three different time points after venom in-
oculation (M1 - 0.5 h; M2 - 6 h; M3 - 24 h), animals 
were monitored to assess the general state, heart and 
respiratory rates, temperature, and edema (pachymeter) 
[9]. Capillary coagulation tests were also performed 
by using blood from the tail vein [6]. Euthanasia was 
practiced 24 h after venom inoculation by using sodium 
thiopental at 150 mg/kg via intraperitoneal. Intracar-
diac blood collection was then performed [3]. 
Blood constituents were assessed in an automa-
tized CC-530 cell counter4 and differential leukocyte 
count were manually performed; the microhematocrit 
method was used to evaluate blood volume, refractom-
etry for plasma protein level, and heat precipitation 
for fibrinogen level [6,7]. Serum was used to assess 
blood urea nitrogen5, creatinine6, and creatine kinase7 
according to Kaneko et al. [7]. 
Samples from the kidneys and rear limb 
muscular tissues were collected for histopathological 
evaluation by the pathology service of the Veterinary 
School of UNOESTE, Presidente Prudente/SP, Brazil, 
according to standard procedures [18]. 
Statistical Analysis
ANOVA was used to establish differences 
between means and the Tukey test to compare para-
metric data. Non-parametric data were analyzed using 
the Kruskal-Wallis test. A P-value less than 0.05 (P 
< 0.05) was considered statistically significant. All 
statistical analyses were carried out using the SAS/
STAT software (version 9.0)8. Data were expressed 
as mean ± SD.
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RESULTS
After venom inoculation, animals from the VS 
and VSM groups showed discomfort, uneasiness, pain, 
retraction, and intense edema of the inoculated limb. 
Limb edema was found to be significantly enhanced in 
inoculated animals than in control animals (P < 0.05) at 
all evaluation time points, the edema being considerably 
higher at M1 (Figure 1). A significant drop in temperature 
(P < 0.05) was noticed at M2 for the VS and VSM groups, 
with mean temperatures of 35.73 ± 0.9ºC and 34.96 ± 
1.26ºC, respectively, in comparison with the control group 
C with a mean temperature of 37.17 ± 0.31ºC. There were 
no statistically significant differences in heart rate and re-
spiratory rate between the VS and VSM groups (P > 0.05).
Lack of blood coagulability was observed in 
three animals at M2, two from the VS group, and one 
from the VSM group. Alterations in transient hematocrit, 
erythrocyte counts, and hemoglobin were observed in the 
inoculated groups, mainly at M1 (P < 0.05), but without 
clinical significance. A statistically significant increase 
in leukocyte counts (P < 0.05) was found in the VS and 
VSM groups at M1 and M2 than in group C (Table 1). 
Neutrophil counts were significantly higher (P < 0.05) 
in the VS group (6.83 ± 1.90 x 103 cells/µL and 6.22 ± 
3.67 × 103 cells/µL at M1 and M2, respectively) and the 
VSM group (4.95 ± 1.57 × 103 cells/µL and 12.19 ± 4.40 
× 103 cells/µL at M1 and M2, respectively), compared to 
that in the control group (2.29 ± 0.55 × 103 cells/µL and 
1.78 ± 0.38 × 103 cells/µL at M1 and M2, respectively). 
Lymphocyte counts were statistically significant different 
(P < 0.05) at M1 in the VS (8.69 ± 5.18 × 103 cells/µL) 
and VSM (5.50 ± 0.94 × 103 cells/µL) groups compared 
with that in the group C (2.56 ± 0.49 × 103 cells/µL).
Figure 1. Left hindlimb edema measures in control and inoculated rats 
treated with anti-venom serum, or both anti-venom serum and Mikania 
glomerata extract at 0.5 h, 6 h, and 24 h. Data are shown as mean ± SD.
Table 1. Hematological parameters in control and inoculated rats treated with anti-venom serum, or both anti-venom serum and Mikania glomerata 
extract at 0.5 h, 6 h, and 24 h. 
Erythrocyte count  
(106 cells/µL)
Hemoglobin 
(g/dL)
Hematocrit  
(%)
Leukocyte count 
(103 cells/µL)
Group C
M1 8.11 ± 0.47Ba 14.58 ± 0.23Ca 43 ± 0.01Ba 5.64 ± 0.88Ba 
M2 6.93 ± 0.38ABb 13.95 ± 0.60Aa 42 ± 0.01Aa 4.24 ± 1.99Ba
M3 6.89 ± 0.26Ab 14.25 ± 0.42Aa 42 ± 0.00Aa 5.20 ± 0.95Aa
Group VS
M1 9.05 ± 0.90ABa 16.75 ± 0.79Ba 49 ± 0.01Aa 16.60 ± 6.75Aa
M2 6.49 ± 0.58Bb 13.87 ± 1.51Ab 41 ± 0.05Ab 10.75 ± 3.32Aab
M3 5.82 ± 0.84Ab 11.78 ± 1.25Bc 36 ± 0.03Ab 8.47 ± 4.26Ab
Group VSM
M1 9.93 ± 0.64Aa 19.08 ± 0.59Aa 53 ± 0.01Aa 11.13 ± 1.87Ab
M2 8.19 ± 0.51Ab 15.35 ± 1.22Ab 45 ± 0.03Ab 17.57 ± 5.48Aa
M3 6.93 ± 1.31Ab 13.12 ± 2.36ABb 39 ± 0.07Ab 8.17 ± 4.32Ab
A,BIdentical uppercase letters indicate no statistically significant difference between time points (P > 0.05). a,bIdentical lowercase letters indicate no 
statistically significant difference between groups (P > 0.05). Data are shown as mean ± SD.
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Urea nitrogen and creatine kinase levels were 
significantly elevated (P < 0.05) in inoculated groups 
(VS and VSM) at M1 and M2, and creatinine was el-
evated at M2 and M3 (Table 2), compared to those in 
the control group. A significant drop in protein levels 
(P < 0.05) was observed in the VS group at all evalu-
ated time points, but interestingly, the VSM group did 
not show statistically significant protein reduction 
(P > 0.05) at M1. Fibrinogen did not show alterations 
at any evaluated time points (P > 0.05).
Histopathological evaluation of animals in the 
VSM group showed mild muscular fiber regeneration and 
moderate edema but no hemorrhages in the inoculated 
limbs, whereas animals in the VS group showed severe 
muscular edema and hemorrhage (P < 0.05). Renal hy-
dropic degeneration, acute tubular necrosis, congestion, 
and hemorrhage were significantly higher in VS and VSM 
groups in contrast to control animals (P < 0.05), but there 
were no statistically significant differences between the 
different modalities of treatment (P > 0.05).
Table 2. Levels of urea nitrogen, creatinine, creatine kinase and plasma fibrinogen, and protein levels in control and inoculated rats treated with anti-
venom serum, or both anti-venom serum and Mikania glomerata extract at 0.5 h, 6 h and 24 h. 
Urea nitrogen 
(mg/dL)
Creatinine  
(mg/dL)
Creatine Kinase 
 (U/L)
Fibrinogen 
(mg/dL)
Protein 
(g/dL)
Group C
M1 39.90 ± 15.60Ba 0.59 ± 0.05Aa 38.9 ± 24.02Ba 300.00 ± 109.54Aa 6.40 ± 0.12Ab
M2 44.90 ± 11.72Ba 0.57 ± 0.04Ba 60.5 ± 36.65Ba 233.33 ± 81.65Aa 6.10 ± 0.27Ab 
M3 47.68 ± 1.85Aa 0.46 ± 0.05Bb 68.05 ± 33.42Aa 266.67 ± 103.28Aa 6.90 ± 0.20Aa
Group VS
M1 50.15 ± 8.81Ab 0.69 ± 0.13Aa 168.97 ± 101.86Aa 266.67 ± 103.28Aa 4.93 ± 0.30Ba
M2 100.00 ± 23.56Aa 0.76 ± 0.12Aa 80.30 ± 9.51Aab 266.67 ± 103.28Aa 4.87 ± 0.24Ba
M3 85.90 ± 57.93Aa 0.77 ± 0.14Aa 30.53 ± 10.85Ab 266.67 ± 103.28Aa 5.03 ± 0.46Ba
Group VSM
M1 66.41 ± 9.1Aa 0.71 ± 0.07Aa 190.00 ± 70.89Aa 350.00 ± 83.66Aa 6.3 ± 0.45Aa
M2 132.2 ± 54.39Aa 0.93 ± 0.36Aa 267.87 ± 122.51Aa 300.00 ± 109.54Aa 5.43 ± 0.34Bb
M3 98.76 ± 88.77Aa 0.74 ± 0.09Aa 25.18 ± 17.13Ab 300.00 ± 109.54Aa 5.23 ± 0.42Bb
A,BIdentical uppercase letters indicate no statistically significant difference between time points (P > 0.05). a,bIdentical lowercase letters indicate no 
statistically significant difference between groups (P > 0.05). Data are shown as mean ± SD.
DISCUSSION
In the present study, the venom dose at which no 
lethal events occurred after 24 h of exposure was estab-
lished based on preliminary studies [5]. Envenomation 
symptoms were consistent with previous reports of bo-
thropic events, in which cytolysins were responsible for 
most clinical symptoms, including local inflammation, 
edema, pain, and necrosis [8,12,19]. Early edema and 
tissue degradation occurs mainly due to proteolytic and 
vasculotoxic effects [1,15] associated with hyaluroni-
dase, phospholipase A2, and esterase actions, related 
to alterations in membrane permeability and release 
of vasoactive agents [4]. Coagulation disturbances are 
secondary to thrombin-related consequences and factor 
X activation, leading to consumption of coagulation 
factors as was observed in some animals in the current 
study [1,17]. Hypothermia is associated with release of 
histamine and bradykinin and it can be present even at 
6 h after venom inoculation [11].
Groups inoculated with venom showed 
leukocytosis with neutrophilia, as was reported by 
others [4,12]. These alterations were associated with 
strong inflammatory reactions, stress responses, or 
both [12].
Increased muscular lesions in response to 
necrosis and rhabdomyolysis linked to phospholipase 
A2 action, hemorrhage, and vascular permeability 
alterations [1,17] were associated with an increase in 
creatine kinase levels [15]; similarly, enhanced blood 
urea nitrogen and creatinine were associated with re-
nal injury of multifactorial pathogenesis that includes 
nephrotoxic or ischemic mechanisms [1,12,19].
Postmortem renal findings included severe 
congestion and hemorrhage, acute tubular necrosis, and 
hydropic degeneration, all of which were consistent with 
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previously reported findings [4] and mechanisms of 
renal injury [1]. Interestingly, histopathological evalu-
ation of animals treated with Mikania glomerata extract 
showed mild muscular fiber regeneration, moderate 
edema, and absence of hemorrhage in the inoculated 
limb, in contrast to the group that received anti-venom 
serum alone, in which muscular edema and hemorrhage 
were severe. These findings agree with experimentally 
identified anti-inflammatory and antihemorrhagic prop-
erties of the Mikania genus against myotoxic, neuro-
toxic, and inflammatory effects of snake venoms [2]. 
The above observations are further supported by the 
findings of other studies in rats that revealed 80% reduc-
tion in hemorrhage area following intradermal injection 
of Bothrops venom and Mikania extract administration 
[14], and reduction of inflammatory cells, edema, and 
hemorrhagic halo 3 h after administration of B. jararaca 
venom and Mikania leaf extract [10].
However, the extract of M. glomerata could 
only partially inhibit phospholipase A2 activity and 
edema caused by Bothrops venom, in contrast to total 
inhibition observed in studies using Crotalus venom, 
explaining the low number of beneficial effects ob-
served in this study [9].
At the inoculated dose, bothropic venom 
caused sub-lethal intoxication in Wistar rats despite 
immediate anti-ophidic serum administration, indi-
cated by alterations in hematological and biochemical 
parameters resulting in muscular and renal lesions. 
CONCLUSION
Mikania glomerata extract at 10 mg/kg did 
not exhibit properties useful in management of 
bothropic envenomation, except amelioration of 
muscular edema and hemorrhage; nevertheless, it 
can possibly be integrated as a supportive measure 
to treat snakebite accidents. Further studies are 
necessary to determine the appropriate dose and 
treatment duration.
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